Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G
Imperial Cancer Research Fund, Cancer Epidemiology Unit, Radcliffe Infirmary, Oxford OX2 6HE.
BMJ. 1999 Jan 9;318(7176):96-100. doi: 10.1136/bmj.318.7176.96.
To describe the long term effects of the use of oral contraceptives on mortality.
Cohort study with 25 year follow up. Details of oral contraceptive use and of morbidity and mortality were reported six monthly by general practitioners. 75% of the original cohort was "flagged" on the NHS central registers.
1400 general practices throughout Britain.
46 000 women, half of whom were using oral contraceptives at recruitment in 1968-9. Median age at end of follow up was 49 years.
Relative risks of death adjusted for age, parity, social class, and smoking.
Over the 25 year follow up 1599 deaths were reported. Over the entire period of follow up the risk of death from all causes was similar in ever users and never users of oral contraceptives (relative risk=1.0, 95% confidence interval 0.9 to 1.1; P=0.7) and the risk of death for most specific causes did not differ significantly in the two groups. However, among current and recent (within 10 years) users the relative risk of death from ovarian cancer was 0.2 (0.1 to 0.8; P=0.01), from cervical cancer 2.5 (1.1 to 6.1; P=0.04), and from cerebrovascular disease 1.9 (1.2 to 3.1, P=0.009). By contrast, for women who had stopped use >/= 10 years previously there were no significant excesses or deficits either overall or for any specific cause of death.
Oral contraceptives seem to have their main effect on mortality while they are being used and in the 10 years after use ceases. Ten or more years after use ceases mortality in past users is similar to that in never users.
描述口服避孕药的使用对死亡率的长期影响。
进行了为期25年随访的队列研究。全科医生每6个月报告口服避孕药的使用情况以及发病率和死亡率的详细信息。原队列中75%的人在英国国民健康服务中心登记册上被“标记”。
英国各地的1400家全科诊所。
46000名女性,其中一半在1968 - 1969年招募时正在使用口服避孕药。随访结束时的中位年龄为49岁。
根据年龄、产次、社会阶层和吸烟情况调整后的死亡相对风险。
在25年的随访期间,共报告了1599例死亡。在整个随访期间,曾经使用过和从未使用过口服避孕药的女性,所有原因导致的死亡风险相似(相对风险 = 1.0,95%置信区间0.9至1.1;P = 0.7),两组中大多数特定原因的死亡风险没有显著差异。然而,在当前使用者和近期(10年内)使用者中,卵巢癌导致的死亡相对风险为0.2(0.1至0.8;P = 0.01),宫颈癌为2.5(1.1至6.1;P = 0.04),脑血管疾病为1.9(1.2至3.1,P = 0.009)。相比之下,对于在10年或更久之前就停止使用口服避孕药的女性,总体或任何特定死因的死亡人数均无显著过多或过少情况。
口服避孕药似乎主要在使用期间以及停止使用后的10年内对死亡率产生影响。停止使用10年或更久之后,过去使用者的死亡率与从未使用者相似。